|
Measure
|
2024 Rate
|
2025 Rate
|
Goal
|
|
Prevention and Screening
|
|
Adult Immunization Status (AIS-E) - Influenza (Total)
|
NR
|
22.07
|
24.30
|
|
Adult Immunization Status (AIS-E) - Pneumococcal (66+)
|
NR
|
41.67
|
52.50
|
|
Adult Immunization Status (AIS-E) - Td/Tdap (Total)
|
NR
|
44.82
|
47.50
|
|
Breast Cancer Screening (BCS-E)
|
NR
|
65.31
|
76.77
|
|
Cervical Cancer Screening (CCS)
|
NR
|
56.78
|
65.03
|
|
Childhood Immunization Status (CIS) - Combo 10
|
NR
|
47.83
|
46.88
|
|
Chlamydia Screening in Women (CHL) Total
|
NR
|
47.83
|
56.04
|
|
Colorectal Cancer Screening (COL-E) -Total
|
NR
|
57.32
|
60.80
|
|
Immunizations for Adolescents (IMA) - Combination 2
|
NR
|
50.00
|
36.86
|
|
Immunizations for Adolescents (IMA) - HPV
|
NR
|
50.00
|
32.70
|
|
Immunizations for Adolescents (IMA) - Meningococcal
|
NR
|
100.00
|
80.90
|
|
Immunizations for Adolescents (IMA) - Tdap
|
NR
|
100.00
|
86.40
|
|
Oral Evaluation, Dental Services (OED) - Total
|
NR
|
NB
|
24.19
|
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - BMI percentile (Total)
|
NR
|
60.00
|
84.30
|
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Nutrition (Total)
|
NR
|
100.00
|
77.20
|
|
Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) - Counseling for Physical Activity (Total)
|
NR
|
93.33
|
74.80
|
|
Respiratory
|
|
Asthma Medication Ratio (AMR) -Total
|
NR
|
66.67
|
84.65
|
|
Cardiovascular
|
|
|
|
|
Controlling High Blood Pressure (CBP)
|
NR
|
55.56
|
73.97
|
|
Diabetes
|
|
Eye Exam for Patients With Diabetes (EED)
|
NR
|
48.84
|
53.33
|
|
Glycemic Status Assessment for Patients With Diabetes (GSD) - Glycemic Status >9.0%
Note: this is an inverse measure, meaning a rate lower than the goal indicates better performance.
|
NR
|
32.56
|
19.71
|
|
Kidney Health Evaluation for Patients With Diabetes (KED) - Total
|
NR
|
32.53
|
58.43
|
|
Behavioral Health
|
|
Antidepressant Medication Management (AMM) - Effective Acute Phase Treatment
|
NR
|
58.82
|
82.80
|
|
Antidepressant Medication Management (AMM) - Effective Continuation Phase Treatment
|
NR
|
32.29
|
67.20
|
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 30 days (Total)
|
NR
|
33.33
|
71.80
|
|
Follow-Up After Hospitalization for Mental Illness (FUH) - 7 days (Total)
|
NR
|
0.00
|
50.00
|
|
Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) - Depression Screening (Total)
|
NR
|
20.13
|
9.30
|
|
Depression Screening and Follow-Up for Adolescents and Adults (DSF-E) - Follow-Up on Positive Screen (Total)
|
NR
|
83.33
|
84.90
|
|
Appropriateness of Use
|
|
Appropriate Treatment for Upper Respiratory Infection (URI) -Total
|
NR
|
72.50
|
85.12
|
|
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) - Total
|
NR
|
60.00
|
54.88
|
|
Use of Imaging Studies for Low Back Pain (LBP) - Total
|
NR
|
62.50
|
75.53
|
|
Access and Availability of Care
|
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Initiation of SUD Treatment - Total (Total)
|
NR
|
35.29
|
46.10
|
|
Initiation and Engagement of Substance Use Disorder Treatment (IET) - Engagement of SUD Treatment - Total (Total)
|
NR
|
17.65
|
15.90
|
|
Prenatal and Postpartum Care (PPC) - Timeliness of Prenatal Care
|
NR
|
25.00
|
89.51
|
|
Prenatal and Postpartum Care (PPC) - Postpartum Care
|
NR
|
62.50
|
88.89
|
|
Utilization
|
|
Child and Adolescent Well-Care Visits (WCV) - Total
|
NR
|
58.49
|
58.56
|
|
Well-Child Visits in the First 30 Months of Life (W30) - (First 15 Months)
|
NR
|
NA
|
85.20
|
|
Well-Child Visits in the First 30 Months of Life (W30) - (15 Months-30 Months)
|
NR
|
100.00
|
90.50
|
Find helpful resources, plan materials, payment information and more.
×
